首页> 外国专利> A method for predicting treatment of tuberculous uveitis in different age groups

A method for predicting treatment of tuberculous uveitis in different age groups

机译:一种预测不同年龄组结核性葡萄膜炎治疗的方法

摘要

method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 u043bu0435u0447u0435u043du0438u00a0 u0443u0432u0435u0438u0442u0430 tuberculosis in different age groups, including the use of ultrasonic u0434u043eu043fu043fu043bu0435u0440u043eu0433u0440u0430u0444u0438u0438 u0434u043bu00a0 u043eu043fu0440u0435u0434u0435u043bu0435u043du0438u00a0 in central artery of retina (cac) and rear short u0446u0438u043bu0438u0430u0440u043du044bu0445 u0430u0440u0442u0435u0440u0438u00a0u0445 (u0437u043au0446u0430) indicators of blood flow, the modification of which register twice prior to placement of u0442u0443u0431u0435u0440u043au0443 u043bu0438u043du043eu0432u044bu0445 samples and through 48 hthe maximum velocity of blood flow u0441u0438u0441u0442u043eu043bu0438u0447u0435u0441u043au043eu0439 register u0438u0437u043cu0435u043du0435u043du0438u00a0 - vs, the minimum u0434u0438u0430u0441u0442u043eu043bu0438u0447u0435u0441u043au043eu0439 speed blood flow - family and peripheral with index u043eu043fu0440u043eu0442u0438u0432u043bu0435u043du0438u00a0 - Ri, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 indicators of blood flow in the u0433u043bu0430u0437u043du0438u0447u043du043eu0439 arteries (ha) of two groups of patients who u0440u0430u043du0436u0438u0440u0443u044eu0442 depending on the u0432u043eu0437u0440u0430u0441 ta, namely: in the first group u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 patients age 18 to 49 years.a second group of patients u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 age 50 to 75 years, and in reducing the u0437u043du0430u0447u0435u043du0438u00a0 vs through a fixed interval on a 10% reduction in ha vs 25.7%, 33.3% and increase the family to Ri - 4 per cent / hour, as well as reduce the vs at 43.47% and family to 35,71% and 7.14% in reducing Ri on u0437u043au0446u0430 in a group of patients from 18 to 49 years, combined with comprehensive therapy by u043eu0447u0430u0433u043eu0432u043eu0439 reaction to it u043du0430u0447u0430u044eu0442 u0438u043cu043cu0443u043du043eu0441u0443u043fu0440u0435u0441u0441u0438u0432u043du0443u044e therapyin reducing the threshold u0437u043du0430u0447u0435u043du0438u00a0 vs through a fixed interval on a 19% reduction in ha vs. 29%, family to 39,28% and increase the Ri - 3,84% in the car, and also lower vs the 48,54% and 55.5% and family at to increase the Ri 15,71% in the group of patients u0437u043au0446u0430 50 - 75 years in combination with poorly expressed u043eu0447u0430u0433u043eu0432u043eu0439 or lack of response to therapy are herbal complex you are to improve local u0433u0435u043cu043eu0434u0438u043du0430u043cu0438u043au0443.
机译:方法 u043f u0440 u043e u0433 u043d u043e u0437 u0438 u0440 u043e u0432 u0430 u043d u0438 u00a0 u043b u0435 u0447 u0435 u043d u043d u0438 u00a0 u0443 u0435 u0438 u0442 u0430在不同年龄段的肺结核,包括使用超声波 u0434 u043e u043f u043f u043b u0435 u0440 u043e u0433 u0440 u0430 u0444 u0438 u0438 u0434 u043b u00a0 u043e u043f u0440 u0435 u0434 u0435 u043b u0435 u043d u0438 u00a0在视网膜中央动脉(cac)和后短 u0446 u0438 u043b u043b u0438 u0430 u0440 u043d u044b u0445 u0430 u0440 u0442 u0435 u0440 u0438 u00a0 u0445( u0437 u043a u0446 u0430)血流指示器,其修改在放置 u0442 u0443 u0431之前先注册两次 u0435 u0440 u043a u0443 u043b u0438 u043d u043e u0432 u044b u0445样本并在48 h内最大血流速度 u0441 u0438 u0441 u0442 u043e u043e u043b u0438 u0447 u0435 u0441 u043a u043e u0439寄存器 u0438 u0437 u043c u0435 u043d u0435 u043d u0438 u00a0-与最小值 u0434 u0438 u0430 u0441 u0442 u043e u043b u0438 u0447 u0435 u0441 u043a u043e u0439加快血液流动-具有索引 u043e u043f u0440 u043e u0442 u0438 u0432 的家庭和外围设备u043b u0435 u043d u0438 u00a0-Ri, u043e u0442 u043b u0438 u0447 u0430 u044e u0449 u0438 u0439 u0441 u00a0, u043e u043f u0440 u0435 u0434 u043 u0433 u043b u0430 u0437 u043d u0438 u0447 u043d u043e u0439两组患者的血管(ha)的血流指标 u0440 u0430 u043d u0436 u0438 u0440 u0443 u044e u0442取决于 u0432 u043e u0437 u0440 u0430 u0441 ta,即:在第一组 u0441 u043e u0441 u0442 u042 u0430 u0432 u043b u00a0 u0435 u0442患者年龄在18至49岁之间。第二组患者 u0441 u043e u0441 u0442 u0430 u0432 u043b u00a0 u0435 u0442年龄在50至75岁之间,并且可以降低 u0437 u043d u0430 u0447 u0435 u043d u0438 u00a0与固定间隔相比,公顷减少10%与25.7%,33.3%相比,家庭增加到Ri-4% /小时,并将18至49岁的一组患者中的降低Ri的比例降低到43.47%,将家人降低到35.71%和7.14%,并采用综合疗法由 u043e u0447 u0430 u0433 u043e u0432 u043e u0439对其做出反应 u043d u0430 u0447 u0430 u044e u0442 u0438 u043c u043c u0443 u043d u043d u043e u0441 u0443 u043f u0440 u0435 u0441 u0441 u0438 u0432 u043d u0443 u044e治疗可降低阈值 u0437 u043d u0430 u0447 u0435 u043d u043d u0438 u00a0相对于固定时间间隔可将ha降低19%相比29%,家庭达到39.28%并增加了汽车的Ri-3,84%,也低于48.54%和55.5%,而家庭成员降低了Ri的15,71%的患者 u0437 u043a u0446 u0430 50-75岁,并伴有表达不佳的 u043e u0447 u0430 u0433 u043e u0432 u043e u0439或对治疗缺乏反应的患者,您需要改善草药u0433 u0435 u043c u043e u0434 u0438 u043d u0430 u043c u0438 u043a u0443。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号